Table 1.
Demographics of patients
| Respondents (N = 1933) | Non respondents (N = 356) | p-valuea | ||||
|---|---|---|---|---|---|---|
| N (%) | Mean (SD) | N (%) | Mean (SD) | |||
| Age | 61.6 (12.1) | 65.7 (12.9) | < 0.001 | |||
| Karnofsky Performance Status (KPS) | 61.6 (16.4) | 46.0 (16.0) | < 0.001 | |||
| Mini Mental State (MMS), total score | 26.9 (3.3) | 25.7 (4.0) | 0.003 | |||
| Time since diagnosis (months) | 32.8 (46.7) | 25.3 (44.3) | 0.001 | |||
| Time on opioids (months) | 5.2 (11.3) | 3.1 (7.1) | 0.002 | |||
| Gender | Female | 922 (47.7) | 165 (47.1) | 0.862 | ||
| Male | 1011 (52.3) | 185 (52.9) | ||||
| Department | Hospitalized patients | 1513 (78.3) | 338 (97.1) | < 0.001 | ||
| Out-patients | 420 (21.7) | 10 (2.9) | ||||
| Status of opioid treatment | Recently initiated, titration | 353 (18.4) | 94 (27.5) | < 0.001 | ||
| Stable dosing | 1564 (81.6) | 248 (72.5) | ||||
| Metastasesb | Bone | 875 (45.3) | 146 (42.0) | 0.266 | ||
| CNS | 104 (5.4) | 28 (8.0) | 0.060 | |||
| Liver | 466 (24.1) | 95 (27.3) | 0.223 | |||
| Lung | 426 (22.0) | 77 (22.1) | 1.000 | |||
| Other | 762 (39.4) | 151 (43.4) | 0.172 | |||
| Cancer diagnosisb | Breast | 268 (13.9) | 33 (9.5) | 0.025 | ||
| Female reproductive organs | 145 (7.5) | 29 (8.3) | 0.584 | |||
| Gastrointestinal | 442 (22.9) | 83 (23.8) | 0.730 | |||
| Haematological | 113 (5.8) | 20 (5.7) | 1.000 | |||
| Head and neck | 105 (5.4) | 20 (5.7) | 0.799 | |||
| Lung | 346 (17.9) | 71 (20.6) | 0.257 | |||
| Other | 168 (8.7) | 40 (11.5) | 0.106 | |||
| Prostate | 230 (11.9) | 34 (9.7) | 0.275 | |||
| Unknown origin | 51 (2.6) | 11 (3.2) | 0.591 | |||
| Urological | 139 (7.2) | 27 (7.7) | 0.737 | |||
| Country | Denmark | 29 (1.5) | 2 (0.6) | 0.213 | ||
| Finland | 30 (1.6) | 0 | 0.010 | |||
| Germany | 273 (14.1) | 178 (50.0) | < 0.001 | |||
| Greece | 5 (0.3) | 0 | 1.000 | |||
| Iceland | 145 (7.5) | 5 (1.4) | < 0.001 | |||
| Italy | 398 (20.6) | 62 (17.4) | 0.195 | |||
| Lithuania | 54 (2.8) | 0 | < 0.001 | |||
| Norway | 475 (24.6) | 88 (24.7) | 0.947 | |||
| Sweden | 119 (6.2) | 16 (4.5) | 0.270 | |||
| Switzerland | 114 (5.9) | 1 (0.3) | < 0.001 | |||
| United Kingdom | 291 (15.1) | 4 (1.1) | < 0.001 | |||
| Reason for not completing all assessment forms | Did not want to complete | 96 (27.8) | ||||
| Too ill | 177 (51.3) | |||||
| Unknown reason | 72 (20.9) | |||||
aP-values from Mann-Whitney U test or Fisher's Exact test (2 × 2-tables)
bSome patients had more than one cancer diagnosis and more than one localization of metastases, consequently the sum of percentages is larger than 100.